Announcing the Digital In Vivo Alliance (DIVA), a precompetitive consortium to develop, validate and promote the use of AI-enabled digital biomarkers in preclinical in vivo research.

SAN FRANCISCO, Oct. 19, 2023 /PRNewswire/ — A milestone event unfolds today with the announcement of the Digital In Vivo Alliance (DIVA), a precompetitive independent consortium of pharmaceutical leaders, innovative biotechs, and the public sector. This collaboration brings together…

Click here to view original post